- Home
- CCEL vs VCSA Comparison
CCEL vs VCSA Comparison
Compare CCEL & VCSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- VCSA
- Stock Information
- Founded
- CCEL 1989
- VCSA 2009
- Country
- CCEL United States
- VCSA United States
- Employees
- CCEL N/A
- VCSA N/A
- Industry
- CCEL Managed Health Care
- VCSA Computer Software: Prepackaged Software
- Sector
- CCEL Health Care
- VCSA Technology
- Exchange
- CCEL Nasdaq
- VCSA Nasdaq
- Market Cap
- CCEL 53.9M
- VCSA 38.3M
- IPO Year
- CCEL 1997
- VCSA N/A
- Fundamental
- Price
- CCEL $6.06
- VCSA $2.55
- Analyst Decision
- CCEL
- VCSA Buy
- Analyst Count
- CCEL 0
- VCSA 4
- Target Price
- CCEL N/A
- VCSA $7.50
- AVG Volume (30 Days)
- CCEL 3.5K
- VCSA 82.7K
- Earning Date
- CCEL 10-22-2024
- VCSA 11-05-2024
- Dividend Yield
- CCEL N/A
- VCSA N/A
- EPS Growth
- CCEL N/A
- VCSA N/A
- EPS
- CCEL N/A
- VCSA N/A
- Revenue
- CCEL $31,641,636.00
- VCSA $1,014,965,000.00
- Revenue This Year
- CCEL $3.70
- VCSA N/A
- Revenue Next Year
- CCEL $10.57
- VCSA N/A
- P/E Ratio
- CCEL N/A
- VCSA N/A
- Revenue Growth
- CCEL 1.93
- VCSA N/A
- 52 Week Low
- CCEL $3.67
- VCSA $2.07
- 52 Week High
- CCEL $9.50
- VCSA $13.00
- Technical
- Relative Strength Index (RSI)
- CCEL 40.96
- VCSA 37.49
- Support Level
- CCEL $6.29
- VCSA $2.47
- Resistance Level
- CCEL $6.80
- VCSA $3.05
- Average True Range (ATR)
- CCEL 0.25
- VCSA 0.23
- MACD
- CCEL -0.00
- VCSA -0.04
- Stochastic Oscillator
- CCEL 0.00
- VCSA 7.89
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
About VCSA Vacasa Inc.
Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.